CONFERENCE - Programme

Technology transfer specialists and leading European business schools, innovative entrepreneurs, big pharma executives’, start-ups’ advisors and investors will guide you along the road from research to market with three thematic "pit" stops:

1. Intellectual Property Rights,
2. Entrepreneurship - Business Planning and
3. Marketing,

plus an interactive "Ask the experts" session with face-to-face meetings with top experts and investors to help you to answer the following questions:

• What to do with my research results? How to protect them?
• Which is my market? How can I convince investors?
• What does business capital entail?
• How to approach potential customers? What do big companies want?
• How to develop a marketing strategy?

The event is designed in a way to be particularly useful for:

• Health specialists (individual researchers, SMEs, FP7 and H2020 project coordinators and partners – all those dealing with exploitation issues).
• Support organisations (Technology Transfer Offices, incubators, clusters, business networks, health professionals’ organizations, innovation agencies, IPR helpdesk etc.).
• Higher education and research structures.
• Policy makers.
• Other innovation stakeholders (i.e. banks, venture capital firms, consultancy companies, National Contact Points, IPR private offices).

Do not miss this key opportunity to share experience, benefit from best practices and engage with peers and investors in face-to-face meetings and networking.

PARTICIPATION IS FREE OF CHARGE. PLEASE NOTE THAT PRE-REGISTRATION IS MANDATORY.

 AGENDA*** 

• Svetlana Klessova, Director, inno TSD, France
• Christian Suojanen, Co-founder and chairman, TTS Global initiative, United Kingdom

• Jeremy Bray, Policy Advisor, Health Directorate, DG Research and Innovation, European Commission
• Svetlana Klessova, Director, inno TSD, France

Academic research can be developed into marketable products via different path: start-up creation (developed in the 2 other pit stops), service contracts, licensing... To this end, IP protection is fundamental.

The speaker and panelists will address the following questions: What to do with research results? What is their value? How to protect them? What about open innovation? First leads towards exploitation (licensing, start up creation...)? Is IPR different between individual research projects and collaborative research projects?

Exploitation of results should be thought of from the beginning of a project. To support this, the project team has developed some annotated templates that are useful for applications to various H2020 instruments.

• Caterina Buonocore, National Contact Point Health, demographic change and wellbeing for Horizon 2020, APRE – Italian Agency for Promotion of European Research, Italy

A major issue when creating a start-up is financing, an overview of possible financing route will be presented. The panel discussion will then provide insights on how to meet VC and how to obtain more general support. Experiences will be shared by a H2M beneficiary and 2 start-up, which have already raised some money.

Some of the points and questions the speaker and panelists will address are: The entrepreneurial mindset: a different perspective of value creation; What is my market? The entrepreneurial approach of market selection; How can I convince investors? What does business planning entail? From idea to business model to business plan?

To support new entrepreneurs, the project team has developed e-learning modules, and MOOC is in its launch process.

• Krisztina Toth, Project Manager, Europa Media, Hungary

Having a good product is not enough, marketing is also extremely important; however, in the pharmaceutical or biotech industry, there are some necessary steps to go through to market a drug. Often a small pharmaceutical company or biotech will not bring its product to market but will rather sell its clinical candidate; the questions then are what are pharmaceutical companies looking for in clinical candidates and how to approach them. Experiences will be shared by a H2M beneficiary. Some of the questions the speaker and panelists will answer are: What is your market? How to approach potential customers? What do big pharma companies want? How to develop a marketing strategy? How to implement your marketing strategy? To support new entrepreneurs, the project team has developed a "how to-do" guidebook

• Peter Häfner, Senior innovation manager, engage AG, Germany

• Svetlana Klessova, Director, inno TSD, France

Speed "dating" – participants will choose when registering for the event with which theme expert they wish to talk to (20 minutes minimum time slots).